IVA
Inventiva S.A.
Phase 3
AI-extracted
lanifibranor
metabolic dysfunction-associated steatohepatitis (MASH)
T-minus 132 days
~ Dec 31, 2026
SEC 6-K
verified 2mo ago
Countdown card →